ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. logo
ACAD

ACADIA Pharmaceuticals Inc. (ACAD)

$15.525.79%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$14.65
Day's Range
$15.535
$12.24
52-Week Range
$28.06
1 month return8.48%
3 month return9.0%
1 year return23.59%
5 year return51.5%

Company Information

Acadia is trailblazing breakthroughs in neuroscience to elevate life. For more than 25 years it has been working at the forefront of healthcare to bring vital solutions to people who need them most. It developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson's disease psychosis. Its late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome, and in early-stage clinical research it is exploring novel approaches to pain management, and cognition and neuropsychiatric symptoms in central nervous system disorders.
OrganizationACADIA Pharmaceuticals Inc.
Employees510
CEOMr. Stephen R. Davis J.D.
IndustryHealth Technology

Analyst Recommendation

based on 21 analysts ratings

Hold
33%
Buy
66%
Hold
0%
Sell

Based on 21 Wall street analysts offering stock ratings for ACADIA Pharmaceuticals Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 22.76%

Current

$15.07

Target

$18.5

Recommendation Trend

Based on 21 analyst

Current1M Ago3M Ago
Buy
7
12
13
Hold
14
13
12
Sell
0
1
1
Consensus
HOLD
HOLD
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
2.4B
Book Value
$2.63
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.33
PEG Ratio
-0.42
Wall Street Target Price
18.5

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
5.75
Enterprise Value
2.1B
Enterprise Value/Revenue
4.05
Enterprise Value/Ebitda
-9.42

Technicals

Beta
0.6
50 Day MA
16.09
200 Day MA
18.47

Institutional Holdings

Baker Bros Advisors LP

25.89%

Vanguard Group Inc

7.98%

FMR Inc

7.66%

State Street Corporation

4.19%

EcoR1 Capital, LLC

3.7%

D. E. Shaw & Co LP

2.91%

Discover more

Frequently Asked Questions

What is ACADIA Pharmaceuticals Inc. share price today?

Can Indians buy ACADIA Pharmaceuticals Inc. shares?

How can I buy ACADIA Pharmaceuticals Inc. shares from India?

Can Fractional shares of ACADIA Pharmaceuticals Inc. be purchased?

What are the documents required to start investing in ACADIA Pharmaceuticals Inc. stocks?

What are today’s High and Low prices of ACADIA Pharmaceuticals Inc.?

What are today’s traded volumes of ACADIA Pharmaceuticals Inc.?

What is today’s market capitalisation of ACADIA Pharmaceuticals Inc.?

What is the 52 Week High and Low Range of ACADIA Pharmaceuticals Inc.?

How much percentage ACADIA Pharmaceuticals Inc. is down from its 52 Week High?

How much percentage ACADIA Pharmaceuticals Inc. is up from its 52 Week low?

What are the historical returns of ACADIA Pharmaceuticals Inc.?

Who is the Chief Executive Officer (CEO) of ACADIA Pharmaceuticals Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*